baber/WOPTO huggingface dataset:
Patent NZ-546157-A (NZ)
Title: Metropolitan wide wireless networking system and method for roaming users
Inventor: WELCH JOHN THOMAS
IPC: H04L12/56
Filed: 2004-09-07
Abstract: An infrastructure-based metropolitan wide multipoint to multipoint wireless networking system for providing a wireless network comprises at least one primary aggregation point (PAP) housing intelligent network servers (INS) that provide centralised services and a series of geographically dispersed intelligent network nodes (INNs) providing point of presence (POP) operations throughout the networking system. The INS and the INNs are interconnected by a series of radio transmission devices so as to provide for metropolitan wide networking.
Patent NZ-548831-A (NZ)
Title: Gas fireplace
Inventor: PIAZZETTA CARLO
Filed: 2006-07-31
Abstract: A gas fireplace (1) has a support and housing frame (2, 3), a gas combustion chamber (9), at least one chimney duct (23) for releasing flue gases, at least one inlet duct (21) for external comburent air leading to the combustion chamber (9) is disclosed. The fireplace has a ventilation and heating circuit (16, 18, 26, 29, 32) designed to suck environment air, and heat and feed it at least partly into the space where the fireplace is located, and at least one motor-driven fan (30) designed to operate in the ventilation and heating circuit. The gas fireplace further comprises at least one silencer device (33) provided along the ventilation and heating circuit.
Patent NZ-560749-A (NZ)
Title: Diosmetin derivatives for the treatment and prevention of thrombotic pathologies
Inventor: VERBEUREN TONY
IPC: A61K31/352
Filed: 2006-02-28
Abstract: Disclosed is the use of diosmetin compounds of formula (I) wherein the substituents are disclosed within the specification in the manufacture of a medicament for the prevention and/or treatment of thrombotic pathologies.
Patent NZ-565937-A (NZ)
Title: Tissue protective peptides and uses thereof
Inventor: CERAMI ANTHONY
IPC: C07K14/705
Filed: 2006-08-07
Abstract: Provided is an isolated polypeptide consisting of no more than 30 amino acid residues, said polypeptide comprising eleven externally-facing amino acid residues of Helix B of erythropoietin, wherein one of said amino acid residues optionally is replaced with a conservative or non-conservative substitution, or a retro-inverso-analogue thereof. The peptide enhances the viability of mammalian cells in vivo and can be used to treat a variety of diseases.
Patent NZ-570407-A (NZ)
Title: Tetrahydronaphthalene derivatives, processes for preparing them and their use as antiinflammatory agents
Inventor: BERGER MARKUS
IPC: A61K31/47
Filed: 2007-03-15
Abstract: Disclosed are tetrahydronaphthalene derivatives of formula (Ia) wherein the radicals R1, R2 and R3 are independently of one another selected from -OH, O-CH3, Cl, F and H, the radical R5 is CF3 and the remaining substituents are as defined in the specification, and their use as anti-inflammatory agents.
Patent NZ-573674-A (NZ)
Title: Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof
Inventor: DELHOMEL JEAN-FRANCOIS
IPC: A61P3/04
Filed: 2007-06-21
Abstract: Disclosed are 1,3-diphenylpropane derivatives as represented by the general formula (I), wherein X1 represents a halogen atom, a halogenated alkyl group, a haloalkoxy group or a haloalkylthio group; X2 represents a hydrogen atom, a halogen atom, or a non-halogenated alkyl group; X3 and X5 represent an unsubstituted alkyl group; X4 represents an alkoxy or alkylthio group which is substituted by a carboxylic acid, ester, amino or unsubstituted alkyl amino group; A represents a carbonyl group, or a -CHR7- group, where R7 is a hydroxy group, or an optionally substituted alkoxy group; D represents a methylene (-CH2-) group; or a stereoisomer, diastereoisomer, enantiomer, pure or mixed, racemic mixture, tautomer, salt, hydrate, solvate, solid form, or mixture thereof. Of particular importance are the compounds 2-[2,6-dimethyl-4-[3-[ 4-(trifluoromethoxy)phenyl]-3-oxo-propyl]phenoxy]-2-methylpropanoic acid and 2-[2,6-dimethyl-4-[3-[4-bromophenyl]-3-oxo-propyl]phenoxy]-2-methylpropanoic acid. Further disclosed is a pharmaceutical composition which comprises a pharmaceutically acceptable support, at least one of compound as defined above, and optionally one or several other therapeutic and/or cosmetic active constituents, for the treatment of a complication associated with metabolic syndrome, insulin resistance, diabetes, dyslipidemias, atherosclerosis, cardiovascular diseases, obesity, hypertension, inflammatory diseases, neurodegenerative pathologies, or cancers.
Patent NZ-574191-A (NZ)
Title: Plant transformation using DNA minicircles
Inventor: CONNER ANTHONY
IPC: A01H5/00
Filed: 2010-01-26
Abstract: Provided is a vector comprising first and second recombinase recognition sequences, wherein the recombinase recognition sequences, and any sequence between the recombinase recognition sequences, are derived from plant species, wherein the vector is capable of producing a minicircle DNA molecule in the presence of a suitable recombinase, and wherein the vector further comprises, between the recombinase recognition sequences, at least one T-DNA borderlike sequences. The recombinase recognition sequence can be LoxP-like sequences derived from a plant species. Further provided are methods of using the vectors to produce transgenic plants.
Patent NZ-577616-A (NZ)
Title: Human antibodies to human delta like ligand 4
Inventor: PAPADOPOULOS NICHOLAS J
IPC: A61K39/395
Filed: 2007-12-14
Abstract: Disclosed is a human antibody or antibody fragment which specifically binds an epitope within the N-terminus-DSL domain of human delta like ligand 4 (hDll4). Also disclosed are isolated nucleic acid molecules, vectors, isolated host cells, methods for producing the antibody and the use of the antibody in the manufacture of a medicament for use to attenuate or inhibit a Dll4-related disease.
Patent NZ-579701-A (NZ)
Title: Glove with a reinforced elastomeric material applied to an inside surface a cuff portion of the glove
Inventor: DAY JONATHAN
IPC: A41D19/00
Filed: 2006-02-21
Abstract: A glove is disclosed. The glove comprises a hand portion and a wrist portion extending from the hand portion, and terminating in a hand insertion opening. The wrist portion of the glove, at least in the region of the opening, is reinforced with elastomeric material applied to the surface of the wrist portion which will form an inside surface of the glove. (62) Divided Out of 561783
Patent NZ-580996-A (NZ)
Title: Process for converting hydrocarbon feedstocks with electrolytic recovery of halogen
Inventor: GROSSO PHILLIP
IPC: C25B3/00
Filed: 2008-05-14
Abstract: Disclosed is a continuous process for converting a hydrocarbon feedstock into higher hydrocarbons, comprising: (a) forming alkyl halides by reacting molecular halogen with a hydrocarbon feedstock under process conditions sufficient to form alkyl halides and hydrogen halide; (b) forming higher hydrocarbons and hydrogen halide by contacting the alkyl halides with a catalyst under process conditions sufficient to form higher hydrocarbons and hydrogen halide; (c) separating the higher hydrocarbons from the hydrogen halide; (d) converting the hydrogen halide into hydrogen and molecular halogen electrolytically, thereby allowing the molecular halogen to be reused; and (e) repeating steps (a) through (d) a desired number of times.
Patent NZ-586871-A (NZ)
Title: Designing a foot orthotic using an array of movable pins applied in sequential series to plantar surface of foot
Inventor: MILLER J
IPC: A61F5/14
Filed: 2009-01-16
Abstract: Disclosed are methods and systems for design of a foot orthotic, and a foot orthotic device designed in accord therewith. More specifically described is an individualized foot orthotic device to correct and/or restore the ideal alignment and/or positioning of foot structures. In the method, sequential pressure is applied to regions on a plantar foot surface, and positional information is obtained about each region. Based on the positional information, an orthotic profile is determined, for design of one or more custom, individualized foot orthotic devices for a subject.
Patent NZ-586976-A (NZ)
Title: Inhaler with blister strip drive engaging in crease between blister pocket and strip
Inventor: GIBBINS GRAHAM
IPC: A61M15/00
Filed: 2009-01-22
Abstract: An inhaler is disclosed. It comprises a housing to receive a strip having a surface and a plurality of blister pockets depending from said surface. Each blister pocket contains a dose of medicament for inhalation by a user. The inhaler has a blister strip drive mechanism including a blister strip drive member shaped to contact the strip along a line defined by the crease between a blister pocket and said surface, to drive said strip. Such contouring of the drive mechanism is to lessen the likelihood of damage to the blister strip.
Patent NZ-601603-A (NZ)
Title: A water heating system with water flow directable between storage tank, solar heater and instantaneous heater using pumps
Inventor: PUSSELL PATRICK
IPC: F24D17/00
Filed: 2009-11-03
Abstract: Disclosed is a hot water system (80) comprising a water storage tank (14), an instantaneous-type water heater (12), a first pump (84), a second pump (100), a solar panel (98) and a controller (42). The storage tank (14) has first (92) and second inlets (110) and first (94), second (116) and third (24) outlets. The instantaneous-type water heater (12) has an inlet (18), in fluid communication with the first outlet (94) of the tank (14), and an outlet (20). The water heater (12) is adapted to energise in response to a flow of water through the water heater (12). The first pump (84) has an inlet (86), in fluid communication with the outlet (20) of the water heater (12), and an outlet (90), in fluid communication with the first inlet (92) of the tank (14). The second pump (100) has an inlet (114) in fluid communication with the mains water supply (26) and the second outlet (116) of the tank (14), and an outlet (102). The solar panel (98) has an inlet (104) in fluid communication with the outlet (102) of the second pump (100) and an outlet (108) in fluid communication the second inlet (110) of the tank (14). The controller (42) is adapted to selectively energise the first (84) and/or the second pump (100) and cause water to circulate between the water heater (12) and the tank (14) and/or between the at least one solar panel (98) and the tank (14) respectively.
Patent NZ-601780-A (NZ)
Title: Amino Acid Prodrugs
Inventor: CHANDRAN V
IPC: A61K/
Filed: 2004-07-29
Abstract: Provided is a drug-conjugate product obtained by reacting the drug with an alpha-amino acid selected from Lys, Leu, He, Gly, Asp, Glu, Met, Ala, Val, His, Nor, Arg, Phe, Trp, Hsr, Car, Ort, Cav, Asn, GIn, Can, Tau, Djk, GABA, Cys, Dcy and Sar, under conditions effective to form a compound having a covalent bond between the drug and the amino acid, wherein the drug is selected from a list of specified drugs (including ibuprofen and aspirin).
Patent NZ-605706-A (NZ)
Title: Method for detecting molecular interactions
Inventor: BERNARDI THIERRY
IPC: G01N11/10
Filed: 2011-06-30
Abstract: Disclosed is a method for detecting interactions in a solution comprising the following steps:, a. introducing into a solution at least one first substance and at least one second substance that can interact with said first substance; , b. introducing into the solution obtained in step a) at least two magnetic or magnetisable particles, said particles resting on a surface immersed in said solution; , c. determining the interaction of said substances by application of an electric, magnetic or electromagnetic field designed to set said particles in motion, the interaction between said substances being detected when the mobility of said particles on said surface is changed.
Patent NZ-607892-A (NZ)
Title: Tfpi inhibitors and methods of use
Inventor: REIMER ULF
IPC: C07K7/08
Filed: 2009-12-21
Abstract: Disclosed is cyclic peptide that binds Tissue Factor Pathway Inhibitor (TFPI), comprising the defined sequence of 22 or 23 amino acids. The peptides are useful in treating bleeding disorders. The peptide may include non-natural amino acids.
Patent NZ-611084-A (NZ)
Title: Interphalangeal joint implant methods and apparatus
Inventor: MICHAEL GRAHAM
IPC: A61F2/42
Filed: 2013-05-24
Abstract: An interphalangeal joint implant includes a proximal phalanx component Fig 3A the stem 114, 116 of which is to be inserted into a bore drilled from the cut distal end of the proximal phalanx and a distal phalanx component Fig 3B the stem 130 of which is to be inserted into a bore drilled from the cut proximal end of the distal phalanx. After the components have been inserted into the respective bones, they are joined together with the bases 118, 128 of the respective components face to face, the components being held together at a required fixed angle by complementary locking structures such as arms 132 projecting from the base of one component into a bore 124 in the other component, with detents 134 on the ends of the arms being snap captured within apertures 122 in the wall of the bore of the other component, and projections 120 being captured in the holes 136. The engaged locking structures prevent movement between the base plates in all directions. The implant is useful for both toes and fingers.
Patent NZ-621149-A (NZ)
Title: System and method for image registration of multiple video streams
Inventor: DILLAVOU MARCUS W
IPC: G16H20/30
Filed: 2012-08-10
Abstract: Disclosed is a method for image registration. The method comprises receiving a first image representing a first element from a local device; and receiving a second image representing a second element physically disposed remotely from the first element from a remote device. The second image is received in a transformed state resulting, at least in part, from a skew, shift, crop, translation, or combination thereof of the second image during transmission. A common field of interest is generated based on the first image and the second image such that the presence of at least one of the first element and the second element is spatially registered relative to the other of the first element and the second element. The common field of interest is generated by de-transformation of at least the second image and wherein the de-transformation comprises applying one or more image transforms to one or more of the first image and the second image. The one or more image transforms are based on a first transformation characteristic of one or more of the local device and the remote device and a second transformation characteristic resulting from transmission of one or more of the first image and the second image. The common field of interest is rendered and the first element and the second element in the common field of interest are rendered to a remote viewer and a local viewer with a substantially similar alignment and orientation.
Patent NZ-630124-A (NZ)
Title: Estrogen receptor modulators and uses thereof
Inventor: SMITH NICHOLAS D
IPC: C07D471/04
Filed: 2013-03-14
Abstract: Described herein are fused heterocyclic substituted alkene compounds that are estrogen receptor modulators of formula (III) (indazole), formula (XI) (benzo[d]thiazole) or formula (VI) (imidazo[1,2-a]pyridine). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such estrogen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon estrogen receptors. Examples of the compounds include: (E)-3-(4-((E)-1-(Benzo[d]thiazol-5-yl)-2-(3-cyano-5-(trifluoromethoxy)pyridin-2-yl)-2-cyclobutylvinyl)phenyl)acrylic acid; (E)-3-(4-((E)-2-(4-Chloro-2-cyanophenyl)-2-cyclobutyl-1-(imidazo[1,2-a]pyridin-6- yl)vinyl)phenyl)acrylic acid; and (E)-3-(4-((E)-2-Cyclobutyl-1-(3-fluoro-1H-indazol-5-yl)-2-(5-(trifluoromethyl)pyrimidin-4-yl)vinyl)phenyl)acrylic acid.
Patent NZ-702814-A (NZ)
Title: Unitary biochip providing sample-in to results-out processing and methods of manufacture
Inventor: TAN EUGENE
IPC: G01N35/00
Filed: 2011-03-09
Abstract: Disclosed is a biochip, a system for processing a biological sample, a method of manufacturing a biochip, a method of performing sample-in to result-out automated electrophoresis, a system for providing at least two types of sample-in to results-out processing for at least one biological sample and a reagent storage container. The biochip which upon insertion into an electrophoresis instrument which has a pneumatic, thermal, high voltage and optical subsystems and a process controller generates a nucleic acid sequencing or sizing profile from at least one sample. The biochip comprises a microfluidic processing subassembly; a fluidic subassembly and a separating and detection sub-assembly. The microfluidic processing subassembly is in connection with a fluidic subassembly and a pneumatic subassembly comprising at least one chamber adapted to receive a sample. The fluidic subassembly comprises a fluidic plate and at least one fluid transport channel and an amplification chamber adapted to connect to the thermal subsystem. The pneumatic subassembly is adapted to connect to the pneumatic subsystem of the electrophoresis instrument and to the subassemblies of the biochip. The pneumatic subassembly comprises a pneumatic plate ad one or a plurality of drive lines to pneumatically drive fluids on instruction from the process controller. The separation and detection subassembly is adapted to connect to the high voltage and optical subsystems and process controller on the electrophoresis instrument. The separation and detection subassembly comprises a separation channel, and a detection region positioned to send signals from each of the said channels to the optical subsystems on the instrument.
Patent NZ-705665-A (NZ)
Title: Magnetic removal or identification of damaged or compromised cells or cellular structures
Inventor: KRUG KRISTIE MARIE
IPC: B03C1/00
Filed: 2013-08-23
Abstract: A composition comprising: a) particles comprising a magnetic substrate, the magnetic substrate characterized by a magnetic susceptibility greater than zero, and a chargeable silicon-containing compound, the chargeable silicon-containing compound coating at least a portion of the magnetic substrate; and b) viable sperm cells and damaged or dead sperm cells, the particles binding to the damaged or dead sperm cells solely through an electrical charge interaction.
Patent NZ-708421-A (NZ)
Title: Modular building structures improvements
Inventor: TREMBLAY MICHELLE
IPC: F16S3/08
Filed: 2011-05-06
Abstract: A measurement free system for building a demountable and re-assemblable building structure includes posts, main beams and joists, and sub-joists that can be all fastened together with integral interlocking fastening elements to provide a reconfigurable building. In particular the system includes a demountable ceiling anchor system with at least two joists each having receiving elements located at predetermined positions along the joist for receiving a ceiling furring strip receiving element, a plurality of furring strip receiving elements each adapted to receive a ceiling furring strip and disposed perpendicular to the joists, and a plurality of furring strips to be inserted into the ceiling furring strip receiving elements. When the furring strips are inserted in the ceiling furring strip receiving elements they form a planar surface to receive a ceiling surface.
Patent NZ-721718-A (NZ)
Title: Triazine compound and use thereof for medical purposes
Inventor: NAGAMORI HIRONOBU
IPC: C07D471/10
Filed: 2015-02-19
Abstract: Provided is a compound which has a mPGES-1 inhibitory activity and is useful for the prevention or treatment of pain, rheumatism, osteoarthritis, fever, Alzheimer’s disease, multiple sclerosis, arteriosclerosis, glaucoma, ocular hypertension, ischemic retinal diseases, systemic sclerosis and malignant tumors including colorectal cancer. The present invention relates to a compound represented by formula [I] [wherein each symbol is as defined in the description] or a pharmaceutically acceptable salt thereof.
Patent NZ-727066-A (NZ)
Title: Preparation of a solid form of gadobenate dimeglumine
Inventor: MAZZON ROBERTA
IPC: C07C227/38
Filed: 2015-07-20
Abstract: The present invention relates to a process for the preparation of a solid form of the gadobenate dimeglumine compound that comprises obtaining a solution of the said compound in a suitable solvent A wherein the amount by weight of the water optionally present in the solution is at most equal to or lower than the amount by weight of the gadobenate dimeglumine comprised in the solution and adding the obtained solution to an organic solvent B, acting as an appropriate antisolvent and favoring the formation of a solid form of the gadobenate dimeglumine that can be collected by filtration.
Patent NZ-733226-A (NZ)
Title: Crystalline forms of grapiprant
Inventor: SMITH MELISSA
IPC: C07D487/04
Filed: 2015-03-05
Abstract: The present disclosure provides a crystalline form of grapiprant selected from the group consisting of Form X, Form X2, Form X3, Form F, Form K, Form L, Form M, and Form N. Also provided is a pharmaceutical composition, the composition comprising at least one crystalline form of grapiprant, and at least one pharmaceutically acceptable excipient, wherein the crystalline form of grapiprant is selected from the group consisting of Form X, Form X2, Form X3, Form F, Form K, Form L, Form M, and Form N. Other aspects of the disclosure provide a process for preparing a substantially pure crystalline Form A of grapiprant. The process comprises contacting grapiprant at ambient temperature with a solvent comprising dichloromethane and acetone to form a saturated or a near saturated solution. Crystals of the substantially pure crystalline Form A of grapiprant are formed.
Patent NZ-733853-A (NZ)
Title: Sealing foil liners to containers
Inventor: CHISHOLM BRIAN
IPC: B65B51/10
Filed: 2016-03-04
Abstract: An apparatus (12, 112) for sealing a foil liner (14) to a container (10). The apparatus (12, 112) comprises a seal head (26, 126) that includes a body (32, 132) having a first end (34, 134), a second end (36, 136), and an axis (B) extending through the first end (34, 134) and second end (36, 136). The body (32, 132) further includes a sealing surface (38, 138) at the second end (36, 136) thereof facing away from the first end (34, 134). The seal head (26, 126) further includes fluid path(s) (48, 148) for passing fluid through and out of the seal head (26, 126) and onto the foil liner (14). The apparatus provides for a method of sealing that will prevent, or at least minimize, the formation of wrinkles or tears in the foil liner as a result of sealing the foil liner to a sealing surface of a container, said wrinkles caused by expansion of the foil liner due to a hot-filled product and/or heat applied to the peripheral edge of the liner during sealing.